MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$63,026K
EPS
-$1.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
25,920
17,595
-91,930*
14,142
General and administrative
21,933
17,565
9,985*
13,965
Total operating expenses
47,853
35,160
-81,945
28,107
Gain from operations
-47,853
-35,160
81,945*
-28,107
Interest income
4,343
3,935
2,466*
1,731
Other income
-
-
-8,296*
4,149
Change in fair value of warrant liabilities
19,300
188,360
-2,807,435*
790,457
Total other expense, net
-14,957
-184,425
2,801,605*
-784,577
Net gain
-62,810
-219,585
2,883,549*
-812,684
Unrealized loss on available for sale marketable securities
-216
-747
36
-2
Total other comprehensive loss
-216
-747
36*
-2
Comprehensive gain
-63,026
-220,332
2,883,584
-812,686
Basic EPS
-1.16
-5.11
292.101
-121.63
Diluted EPS
-1.16
-5.11
292.101
-121.63
Basic Average Shares
54,304,456
43,011,544
9,871,866*
6,681,794
Diluted Average Shares
54,304,456
43,011,544
9,871,866*
6,681,794
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive gain
-$63,026K
(95.99%↑ Y/Y)
Net gain
-$62,810K
(96.01%↑ Y/Y)
Total other
comprehensive loss
-$216K
(-2300.00%↓ Y/Y)
Gain from operations
-$47,853K
(82.55%↑ Y/Y)
Total other expense,
net
-$14,957K
(98.85%↑ Y/Y)
Unrealized loss on
available for sale...
-$216K
(-2300.00%↓ Y/Y)
Interest income
$4,343K
(708.75%↑ Y/Y)
Total operating
expenses
$47,853K
(-82.55%↓ Y/Y)
Change in fair value of
warrant liabilities
$19,300K
(-98.52%↓ Y/Y)
Research and development
$25,920K
(-90.09%↓ Y/Y)
General and
administrative
$21,933K
(71.55%↑ Y/Y)
Buy us a coffee
Vor Biopharma Inc. (VOR)
Vor Biopharma Inc. (VOR)